Farnaz Vahidnia1, Susan L Stramer2, Debra Kessler3, Beth Shaz3, German Leparc4, David E Krysztof2, Simone A Glynn5, Brian Custer6,7. 1. Blood Systems Research Institute, 270 Masonic Avenue, San Francisco, CA, 94118, USA. Fvahidnia@bloodsystems.org. 2. American Red Cross, Gaithersburg, MD, USA. 3. New York Blood Center, New York, NY, USA. 4. OneBlood, Tampa, FL, USA. 5. National Heart, Lung and Blood Institute, Bethesda, MD, USA. 6. Blood Systems Research Institute, 270 Masonic Avenue, San Francisco, CA, 94118, USA. 7. University of California San Francisco, San Francisco, CA, USA.
Abstract
PURPOSE: Blood donors are considered to be one of the healthiest populations, but relatively little is known about their perceived quality of life. The objective was to examine HRQOL in donors infected with HIV, HBV, HCV or HTLV and a comparison group. METHODS: Donors with confirmed viral infection (cases) and donors who tested false-positive (controls) participated in a multicenter study of US blood donors (2010-2013), funded by the National Heart, Lung and Blood Institute (NHLBI). HRQOL was measured by the EuroQol Five Dimension (EQ-5D) instrument and EQ-5D visual analogue scale (VAS). The lower 25th ‰ of EQ-5D index or VAS score of controls was defined as a "lower HRQOL." RESULTS: A total of 1574 controls completed the HRQOL assessment with a mean EQ-5D index of 0.94 (SD = 0.10) and EQ-VAS of 87.6 (SD = 10.6). Mean EQ-5D index for 192 HIV-, 315 HCV- and 195 HTLV-positive donors were significantly lower than the controls (0.86, 0.83 and 0.87; SD = 0.18, 0.20 and 0.16, respectively, p < 0.001). HBV-positive donors (n = 290) had a similar mean EQ-5D index (0.93, SD = 0.14, p = 0.05) to controls. Anxiety/depression was reported by 34 % of cases, compared with 13 % of controls. In multivariable modeling, the odds of lower HRQOL in HIV, HBV, HCV and HTLV cases were 2.1, 1.6, 2.6 and 2.3 times that of controls, respectively (p < 0.05). CONCLUSIONS: HRQOL reported by blood donors with recent viral infections was relatively high but lower than controls. On average, HRQOL among HCV-positive donors was the lowest and HBV-positive donors reported scores similar to donors without infection.
PURPOSE: Blood donors are considered to be one of the healthiest populations, but relatively little is known about their perceived quality of life. The objective was to examine HRQOL in donors infected with HIV, HBV, HCV or HTLV and a comparison group. METHODS: Donors with confirmed viral infection (cases) and donors who tested false-positive (controls) participated in a multicenter study of US blood donors (2010-2013), funded by the National Heart, Lung and Blood Institute (NHLBI). HRQOL was measured by the EuroQol Five Dimension (EQ-5D) instrument and EQ-5D visual analogue scale (VAS). The lower 25th ‰ of EQ-5D index or VAS score of controls was defined as a "lower HRQOL." RESULTS: A total of 1574 controls completed the HRQOL assessment with a mean EQ-5D index of 0.94 (SD = 0.10) and EQ-VAS of 87.6 (SD = 10.6). Mean EQ-5D index for 192 HIV-, 315 HCV- and 195 HTLV-positive donors were significantly lower than the controls (0.86, 0.83 and 0.87; SD = 0.18, 0.20 and 0.16, respectively, p < 0.001). HBV-positive donors (n = 290) had a similar mean EQ-5D index (0.93, SD = 0.14, p = 0.05) to controls. Anxiety/depression was reported by 34 % of cases, compared with 13 % of controls. In multivariable modeling, the odds of lower HRQOL in HIV, HBV, HCV and HTLV cases were 2.1, 1.6, 2.6 and 2.3 times that of controls, respectively (p < 0.05). CONCLUSIONS: HRQOL reported by blood donors with recent viral infections was relatively high but lower than controls. On average, HRQOL among HCV-positive donors was the lowest and HBV-positive donors reported scores similar to donors without infection.
Entities:
Keywords:
Acute viral hepatitis; Blood donors; EQ-5D; HIV infection; HTLV infection; Health-related quality of life
Authors: Usha K Sharma; Susan L Stramer; David J Wright; Simone A Glynn; Sigurd Hermansen; George B Schreiber; Steven H Kleinman; Michael P Busch Journal: Transfusion Date: 2003-02 Impact factor: 3.157
Authors: Gustaf Edgren; Trung Nam Tran; Henrik Hjalgrim; Klaus Rostgaard; Agneta Shanwell; Kjell Titlestad; Agneta Wikman; Rut Norda; Casper Jersild; Louise Wideroff; Gloria Gridley; Johanna Adami; Mads Melbye; Olof Nyrén; Marie Reilly Journal: Transfusion Date: 2007-11 Impact factor: 3.157
Authors: Fasiha Kanwal; Ian M Gralnek; Paul Martin; Gareth S Dulai; Mary Farid; Brennan M R Spiegel Journal: Ann Intern Med Date: 2005-05-17 Impact factor: 25.391
Authors: Carolina Rosadas; Tatiane Assone; Marina Yamashita; Adine Adonis; Marzia Puccioni-Sohler; Marisa Santos; Arthur Paiva; Jorge Casseb; Augusto C P Oliveira; Graham P Taylor Journal: PLoS Negl Trop Dis Date: 2020-10-16
Authors: Ricardo Henrique-Araújo; Lucas C Quarantini; André C Caribé; Felipe C Argolo; Ana Paula Jesus-Nunes; Mychelle Morais-de-Jesus; Adriana Dantas-Duarte; Tayne Miranda Moreira; Irismar Reis de Oliveira Journal: Braz J Infect Dis Date: 2019-07-22 Impact factor: 3.257